Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Bulent Ozpolat

Assoc. Prof.Dr.

Houston Methodist

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

30%

Biochemistry

30%

Cancer Biology

60%

Targeted Therapy

30%

Microrna Research

20%

Kinase Biology

20%

Epithelial-mesenchymal Transition

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study.

Article Link

Year:

2022

Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulation.

Article Link

Year:

2022

Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer.

Article Link

Year:

2022

Simvastatin-loaded liposome nanoparticles treatment for uterine leiomyoma in a patient-derived xenograft mouse model: a pilot study.

Article Link

Year:

2022

RNAi-based therapeutics and tumor targeted delivery in cancer.

Article Link

Year:

2022

miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K.

Article Link

Year:

2022

CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.

Article Link

Year:

2021

Redirecting host preexisting influenza A virus immunity for cancer immunotherapy.

Article Link

Year:

2021

Novel inhibitors of eukaryotic elongation factor 2 kinase: In silico, synthesis and in vitro studies.

Article Link

Year:

2021

Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression.

Article Link

Year:

2021

Collaborators6

Bulent Ozpolat

The University of Texas MD Anderson Cancer Center

UNITED STATES

Mostafa Borahay

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES

HAMADA MOKHLIS

The University of Texas MD Anderson Cancer Center

UNITED STATES

Caroline Chung

Vice President & Chief Data Officer

The University of Texas MD Anderson Cancer Center

UNITED STATES

Joseph Butner

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Martina Tesikova

Associate Professor

University of South-Eastern Norway

NORWAY

How do I reach out?

Meet Kite AI